Journal of Biological Engineering,
Journal Year:
2023,
Volume and Issue:
17(1)
Published: Sept. 26, 2023
Mastitis
poses
a
major
threat
to
dairy
farms
globally;
it
results
in
reduced
milk
production,
increased
treatment
costs,
untimely
compromised
genetic
potential,
animal
deaths,
and
economic
losses.
Streptococcus
agalactiae
is
highly
virulent
bacteria
that
cause
mastitis.
The
administration
of
antibiotics
for
the
this
infection
not
advised
due
concerns
about
emergence
antibiotic
resistance
potential
adverse
effects
on
human
health.
Thus,
there
critical
need
identify
new
therapeutic
approaches
combat
One
promising
target
development
antibacterial
therapies
transmembrane
histidine
kinase
bacteria,
which
plays
key
role
signal
transduction
pathways,
secretion
systems,
virulence,
resistance.In
study,
we
aimed
novel
natural
compounds
can
inhibit
kinase.
To
achieve
goal,
conducted
virtual
screening
224,205
compounds,
selecting
top
ten
based
their
lowest
binding
energy
favorable
protein-ligand
interactions.
Furthermore,
molecular
docking
eight
selected
five
inhibitors
with
was
performed
evaluate
respect
top-screened
compounds.
We
also
analyzed
ADMET
properties
these
assess
drug-likeness.
two
(ZINC000085569031
ZINC000257435291)
(Tetracycline)
demonstrated
strong
affinity
were
subjected
dynamics
simulations
(100
ns),
free
landscape,
calculations
using
MM-PBSA
method.Our
suggest
have
serve
as
effective
be
utilized
veterinary
medicine
mastitis
after
further
validation
through
clinical
studies.
Journal of Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
66(12), P. 8281 - 8287
Published: June 6, 2023
Heterobifunctional
PROTAC
degraders
are
gaining
attention
as
a
differentiated
therapeutic
modality
with
the
potential
for
oral
dosing
in
clinic.
Belonging
to
beyond
Rule
of
Five
domain
physicochemical
property
space,
we
have
sought
understand
determinants
absorption
this
class
molecules
rapid
development
novel
agents.
We
collected
large
data
set
from
that
been
dosed
orally
and
intravenously
rats
estimate
fraction
absorbed
dosing.
Through
estimation,
effects
differential
hepatic
clearance
normalized,
allowing
better
assessment
absorption.
demonstrate
less
permissive
than
mice.
The
properties
then
evaluated
once
compounds
rank-ordered
by
absorbed.
derive
suggested
design
constraints
on
associated
higher
probability
being
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
191, P. 106774 - 106774
Published: April 17, 2023
Because
genetic
alterations
including
mutations,
overexpression,
translocations,
and
dysregulation
of
protein
kinases
are
involved
in
the
pathogenesis
many
illnesses,
this
enzyme
family
is
target
drug
discovery
programs
pharmaceutical
industry.
Overall,
US
FDA
has
approved
74
small
molecule
kinase
inhibitors,
nearly
all
which
orally
effective.
Of
drugs,
thirty-nine
block
receptor
protein-tyrosine
kinases,
nineteen
nonreceptor
twelve
directed
against
protein-serine/threonine
four
dual
specificity
kinases.
The
data
indicate
that
65
these
medicinals
for
management
neoplasms
(51
solid
tumors
such
as
breast,
colon,
lung
cancers,
eight
nonsolid
leukemia,
six
both
types
tumors).
Nine
FDA-approved
inhibitors
form
covalent
bonds
with
their
enzymes
they
accordingly
classified
TCIs
(targeted
inhibitors).
Medicinal
chemists
have
examined
physicochemical
properties
drugs
Lipinski's
rule
five
(Ro5)
a
computational
procedure
used
to
estimate
solubility,
membrane
permeability,
pharmacological
effectiveness
drug-discovery
setting.
It
relies
on
parameters
molecular
weight,
number
hydrogen
bond
donors
acceptors,
Log
partition
coefficient.
Other
important
descriptors
include
lipophilic
efficiency,
polar
surface
area,
rotatable
aromatic
rings.
We
tabulated
other
inhibitors.
30
fail
comply
five.
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(15), P. 13106 - 13116
Published: July 30, 2024
Achieving
oral
bioavailability
with
Proteolysis
Targeting
Chimeras
(PROTACs)
is
a
key
challenge.
Here,
we
report
the
in
vivo
pharmacokinetic
properties
mouse,
rat,
and
dog
of
four
clinical
PROTACs
compare
an
internally
derived
data
set.
We
use
NMR
to
determine
3D
molecular
conformations
structural
preorganization
free
solution,
introduce
new
experimental
descriptors,
solvent-exposed
H-bond
donors
(eHBD),
acceptors
(eHBA).
derive
upper
limit
eHBD
≤
2
for
apolar
environments
show
greater
tolerance
other
(eHBA,
polarity,
lipophilicity,
weight)
than
Rule-of-5
compliant
drugs.
Within
set
structurally
related
PROTACs,
that
examples
>
have
much
lower
those
2.
summarize
our
findings
as
"Rule-of-oral-PROTACs"
order
assist
medicinal
chemists
achieve
this
challenging
space.
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: Jan. 8, 2024
Abstract
Antibodies
with
lambda
light
chains
(
λ
-antibodies)
are
generally
considered
to
be
less
developable
than
those
kappa
κ
-antibodies).
Though
this
hypothesis
has
not
been
formally
established,
it
led
substantial
systematic
biases
in
drug
discovery
pipelines
and
thus
contributed
dominance
amongst
clinical-stage
therapeutics.
However,
the
identification
of
increasing
numbers
epitopes
preferentially
engaged
by
-antibodies
shows
there
is
a
functional
cost
neglecting
consider
them
as
potential
lead
candidates.
Here,
we
update
our
Therapeutic
Antibody
Profiler
(TAP)
tool
use
latest
data
machine
learning-based
structure
prediction,
apply
evaluate
developability
risk
profiles
for
based
on
their
surface
physicochemical
properties.
We
find
that
while
human
average
have
higher
issues
-antibodies,
sizeable
proportion
assigned
lower-risk
TAP
should
represent
more
tractable
candidates
therapeutic
development.
Through
comparative
analysis
low-
high-risk
populations,
highlight
opportunities
strategic
design
suggests
would
enrich
-antibodies.
Overall,
provide
context
differing
-
enabling
rational
approach
incorporate
diversity
into
initial
pool
immunotherapeutic
International Journal of Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
661, P. 124418 - 124418
Published: July 2, 2024
There
is
increasing
pharmaceutical
interest
in
deep
eutectic
solvents
not
only
as
a
green
alternative
to
organic
drug
manufacturing,
but
also
liquid
formulation
for
delivery.
The
present
work
introduces
hydrophobic
solvent
(HDES)
the
field
of
lipid-based
formulations
(LBF).
Phase
behavior
mixture
with
2:1
M
ratio
decanoic-
dodecanoic
acid
was
studied
experimentally
and
described
by
thermodynamic
modelling.
Venetoclax
selected
model
atomistic
molecular
dynamics
simulations
mixtures.
As
result,
valuable
insights
were
gained
into
interaction
networks
between
different
components.
Moreover,
HDES
showed
greatly
enhanced
solubilization
compared
conventional
glyceride-based
vehicles,
aqueous
dispersion
limited.
Hence
surfactants
their
ability
improve
addition
Tween
80
resulted
lowest
droplet
sizes
high
vitro
release.
In
conclusion,
combination
surfactant(s)
provides
novel
LBF
potential.
However,
components
must
be
finely
balanced
keep
integrity
solubilizing
HDES,
while
enabling
sufficient
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Oct. 31, 2023
The
lead
optimization
process
in
drug
discovery
campaigns
is
an
arduous
endeavour
where
the
input
of
many
medicinal
chemists
weighed
order
to
reach
a
desired
molecular
property
profile.
Building
expertise
successfully
drive
such
projects
collaboratively
very
time-consuming
that
typically
spans
years
within
chemist's
career.
In
this
work
we
aim
replicate
by
applying
artificial
intelligence
learning-to-rank
techniques
on
feedback
was
obtained
from
35
at
Novartis
over
course
several
months.
We
exemplify
usefulness
learned
proxies
routine
tasks
as
compound
prioritization,
motif
rationalization,
and
biased
de
novo
design.
Annotated
response
data
provided,
developed
models
code
made
available
through
permissive
open-source
license.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
13(11)
Published: Dec. 6, 2023
Organotypic
and
microphysiological
systems
(MPS)
that
can
emulate
the
molecular
phenotype
function
of
human
tissues,
such
as
liver,
are
increasingly
used
in
preclinical
drug
development.
However,
despite
their
improved
predictivity,
development
success
rates
have
remained
low
with
most
compounds
failing
clinical
phases
promising
data.
Here,
it
is
tested
whether
absorption
small
molecules
to
polymers
commonly
for
MPS
fabrication
impact
pharmacological
toxicological
assessments
contribute
high
failure
rates.
To
this
end,
identical
devices
fabricated
from
eight
different
prototypic
physicochemical
properties
analyzed.
It
found
overall
primarily
driven
by
compound
hydrophobicity
number
rotatable
bonds.
differ
>1000-fold
between
polydimethyl
siloxane
(PDMS)
being
absorptive,
whereas
polytetrafluoroethylene
(PTFE)
thiol-ene
epoxy
(TEE)
absorbed
least.
Strikingly,
organotypic
primary
liver
cultures
successfully
flagged
hydrophobic
hepatotoxins
lowly
absorbing
TEE
at
therapeutically
relevant
concentrations,
isogenic
PDMS
resistant,
resulting
false
negative
safety
signals.
Combined,
these
results
guide
selection
materials
facilitate
assays
translatability.
ACS Omega,
Journal Year:
2023,
Volume and Issue:
8(25), P. 23148 - 23167
Published: June 12, 2023
Molecular
generative
artificial
intelligence
is
drawing
significant
attention
in
the
drug
design
community,
with
several
experimentally
validated
proof
of
concepts
already
published.
Nevertheless,
models
are
known
for
sometimes
generating
unrealistic,
unstable,
unsynthesizable,
or
uninteresting
structures.
This
calls
methods
to
constrain
those
algorithms
generate
structures
drug-like
portions
chemical
space.
While
concept
applicability
domains
predictive
well
studied,
its
counterpart
not
yet
well-defined.
In
this
work,
we
empirically
examine
various
possibilities
and
propose
suited
models.
Using
both
public
internal
data
sets,
use
novel
that
predicted
be
actives
by
a
corresponding
quantitative
structure-activity
relationships
model
while
constraining
stay
within
given
domain.
Our
work
looks
at
domain
definitions,
combining
criteria,
such
as
structural
similarity
training
set,
physicochemical
properties,
unwanted
substructures,
estimate
drug-likeness.
We
assess
generated
from
qualitative
points
view
find
definitions
have
strong
influence
on
drug-likeness
molecules.
An
extensive
analysis
our
results
allows
us
identify
best
molecules
anticipate
will
help
foster
adoption
an
industrial
context.
ACS Chemical Neuroscience,
Journal Year:
2024,
Volume and Issue:
15(11), P. 2144 - 2159
Published: May 9, 2024
The
local
interpretable
model-agnostic
explanation
(LIME)
method
was
used
to
interpret
two
machine
learning
models
of
compounds
penetrating
the
blood–brain
barrier.
classification
models,
Random
Forest,
ExtraTrees,
and
Deep
Residual
Network,
were
trained
validated
using
barrier
penetration
dataset,
which
shows
penetrability
in
LIME
able
create
explanations
for
such
penetrability,
highlighting
most
important
substructures
molecules
that
affect
drug
simple
intuitive
outputs
prove
applicability
this
explainable
model
interpreting
permeability
across
terms
molecular
features.
filtered
with
a
weight
equal
or
greater
than
0.1
obtain
only
relevant
explanations.
results
showed
several
structures
are
penetration.
In
general,
it
found
some
nitrogenous
more
likely
permeate
application
these
structural
may
help
pharmaceutical
industry
potential
synthesis
research
groups
synthesize
active
rationally.